Search Results - "Byfield, Stacey Dacosta"

Refine Results
  1. 1

    Age distribution of patients with advanced non-melanoma skin cancer in the United States by Dacosta Byfield, Stacey, Chen, Diana, Yim, Yeun Mi, Reyes, Carolina

    Published in Archives of Dermatological Research (01-11-2013)
    “…The epidemiology of non-melanoma skin cancer (NMSC) is not well understood due to exclusion from most US cancer registries. Patients with at least two claims…”
    Get full text
    Journal Article
  2. 2

    Patterns of colorectal cancer screening and adherence rates among an average-risk population enrolled in a national health insurance provider during 2009-2018 in the United States by Kowalkowski, Henrik, Austin, George, Guo, Yinglong, Miller-Wilson, Lesley-Ann, DaCosta Byfield, Stacey

    Published in Preventive medicine reports (01-12-2023)
    “…While colorectal cancer (CRC) is the second leading cause of cancer-related mortality in the United States (US), outcomes can be improved through timely…”
    Get full text
    Journal Article
  3. 3

    A retrospective analysis of delays in the diagnosis of lung cancer and associated costs by Gildea, Thomas R, DaCosta Byfield, Stacey, Hogarth, D Kyle, Wilson, David S, Quinn, Curtis C

    Published in ClinicoEconomics and outcomes research (01-01-2017)
    “…Diagnosis of lung cancer at advanced stages can result in missed treatment opportunities, worse outcomes, and higher health care costs. This study evaluated…”
    Get full text
    Journal Article
  4. 4

    Real-World Treatment Patterns Among Patients Initiating Small Molecule Kinase Inhibitor Therapies for Thyroid Cancer in the United States by Dacosta Byfield, Stacey A., Adejoro, Oluwakayode, Copher, Ronda, Chatterjee, Debanjana, Joshi, Prashant R., Worden, Francis P.

    Published in Advances in therapy (01-04-2019)
    “…Introduction Little is known about real-world use of small molecule kinase inhibitors (SMKI) for advanced thyroid cancer in the United States. This study…”
    Get full text
    Journal Article
  5. 5

    Treatment and outcomes of gastric cancer among United States‐born and foreign‐born Asians and Pacific Islanders by Byfield, Stacey A. DaCosta, Earle, Craig C., Ayanian, John Z., McCarthy, Ellen P.

    Published in Cancer (01-10-2009)
    “…BACKGROUND: The authors investigated whether stage at diagnosis, cancer treatments, and survival of Asian and Pacific Islander (API) gastric cancer patients in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Real-World Outcomes and Value of First-Line Therapy for Metastatic Non-Small Cell Lung Cancer by DaCosta Byfield, Stacey, Chastek, Benjamin, Korrer, Stephanie, Horstman, Thomas, Malin, Jennifer, Newcomer, Lee

    Published in Cancer investigation (25-11-2020)
    “…Although physicians rely on clinical trial data to guide cancer treatment decisions, patient characteristics and outcomes often differ between real-world and…”
    Get full text
    Journal Article
  8. 8

    Cost of Disease Progression in Patients with Metastatic Breast, Lung, and Colorectal Cancer by Reyes, Carolina, Engel‐Nitz, Nicole M., DaCosta Byfield, Stacey, Ravelo, Arliene, Ogale, Sarika, Bancroft, Tim, Anderson, Amy, Chen, May, Matasar, Matthew

    Published in The oncologist (Dayton, Ohio) (01-09-2019)
    “…Introduction To reduce health care costs and improve care, payers and physician groups are piloting value‐based and episodic or bundled‐care payment models in…”
    Get full text
    Journal Article
  9. 9

    Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non‐Hodgkin's Lymphoma by Reyes, Carolina, Engel‐Nitz, Nicole M., DaCosta Byfield, Stacey, Ravelo, Arliene, Ogale, Sarika, Bancroft, Tim, Anderson, Amy, Chen, May, Matasar, Matthew

    Published in The oncologist (Dayton, Ohio) (01-09-2019)
    “…Introduction To reduce health care costs and improve care, payers and physician groups are switching to quality‐based and episodic or bundled‐care models…”
    Get full text
    Journal Article
  10. 10

    Validation of Non-Small Cell Lung Cancer Clinical Insights Using a Generalized Oncology Natural Language Processing Model by Kenney, Rachel C, Chen, Xiaoren, Shintani, Kazuki, Gagnon, Clara, Liu, John, DaCosta Byfield, Stacey, Ochs, Lorre, Currie, Anne-Marie

    Published in JCO clinical cancer informatics (01-09-2024)
    “…Limited studies have used natural language processing (NLP) in the context of non-small cell lung cancer (NSCLC). This study aimed to validate the application…”
    Get more information
    Journal Article
  11. 11

    Economic impact of multigene panel testing for hereditary breast and ovarian cancer by Byfield, Stacey Dacosta, Wei, Helen, DuCharme, Mary, Lancaster, Johnathan M

    “…Healthcare utilization and costs were compared following 25-gene panel (panel) or single syndrome (SS) testing for hereditary breast and ovarian cancer…”
    Get full text
    Journal Article
  12. 12

    Clinical Guidelines Versus Universal Molecular Testing: Are We Ready to Choose an Optimal Strategy for Lynch Syndrome Identification? by Byfield, Stacey A DaCosta, Syngal, Sapna

    Published in The American journal of gastroenterology (01-11-2008)
    “…Lynch syndrome, also known as hereditary non-polyposis colorectal cancer (HNPCC), is the most common form of inherited colorectal cancer (CRC). Affected…”
    Get full text
    Journal Article
  13. 13

    Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-alpha and TGF-beta by Stuelten, Christina H, DaCosta Byfield, Stacey, Arany, Praveen R, Karpova, Tatiana S, Stetler-Stevenson, William G, Roberts, Anita B

    Published in Journal of cell science (15-05-2005)
    “…We used 2D-cocultures employing fibroblasts of different genetic backgrounds and MCF10A-derived human breast epithelial cells of increasingly malignant…”
    Get full text
    Journal Article
  14. 14
  15. 15

    The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs by Reyes, Carolina, DaCosta Byfield, Stacey, Linke, Rolf, Satram-Hoang, Sacha, Teitelbaum, April H

    Published in Melanoma research (01-04-2013)
    “…Using a large national claims database, this study investigates the differences in survival and healthcare costs of metastatic melanoma patients by the number…”
    Get full text
    Journal Article
  16. 16

    Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre by Jonasch, Eric, Lal, Lincy S., Atkinson, Bradley J., Byfield, Stacey DaCosta, Miller, Lesley Ann, Pagliaro, Lance C., Feng, Chun, Tannir, Nizar M.

    Published in BJU international (01-03-2011)
    “…Study Type – Therapy (case series) Level of Evidence 4 What’s known on the subject? and What does the study add? At this point there is very little known about…”
    Get full text
    Journal Article
  17. 17

    Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents by Dacosta Byfield, Stacey, Yu, Elaine, Morlock, Robert, Evans, Dana, Teitelbaum, April

    Published in Journal of medical economics (01-08-2013)
    “…To refine a claims algorithm for identifying second-line systemic regimens for metastatic colorectal cancer (mCRC) based on clinical evidence and to compare…”
    Get more information
    Journal Article
  18. 18

    Lateral signaling enhances TGF-β response complexity by DaCosta Byfield, Stacey, Roberts, Anita B.

    Published in Trends in cell biology (01-03-2004)
    “…TGF-β elicits context-dependent and cell-specific effects that often appear conflicting, such as stimulation or inhibition of growth, apoptosis or…”
    Get full text
    Journal Article
  19. 19

    Smad-binding defective mutant of transforming growth factor β type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines by TIAN, Fang, DACOSTA BYFIELD, Stacey, PARKS, W. Tony, STUELTEN, Christina H, NEMANI, Deepa, ZHANG, Ying E, ROBERTS, Anita B

    Published in Cancer research (Chicago, Ill.) (01-07-2004)
    “…The role of transforming growth factor beta (TGF-beta) in carcinogenesis is complex, with tumor suppressor and pro-oncogenic activities depending on the…”
    Get full text
    Journal Article
  20. 20

    Abstract P3-14-07: Breast cancer screening disparities among insured women in the Washington DC-Baltimore area by Staib, James, Catlett, Kierstin, Byfield, Stacey Dacosta

    Published in Cancer research (Chicago, Ill.) (15-02-2022)
    “…Background: Breast cancer screening (BCS) gaps have closed between non-Hispanic Black (NHB) and non-Hispanic White women when adjusted for covariates including…”
    Get full text
    Journal Article